178 related articles for article (PubMed ID: 25588686)
1. Toxic Epidermal Necrolysis During Dronedarone Treatment: First Report of a Severe Serious Adverse Event Of A New Antiarrhythmic Drug.
Gecks T; Prochnau D; Franz M; Jung C; Kühnert H; Schliemann S; Figulla HR
Cardiovasc Toxicol; 2015 Oct; 15(4):399-401. PubMed ID: 25588686
[TBL] [Abstract][Full Text] [Related]
2. Dronedarone for atrial fibrillation therapy.
Marzocchi M; Lombardi F
Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):675-83. PubMed ID: 21714598
[TBL] [Abstract][Full Text] [Related]
3. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
[TBL] [Abstract][Full Text] [Related]
4. Dronedarone. atrial fibrillation: too many questions about long-term adverse effects.
Prescrire Int; 2010 Aug; 19(108):149-52. PubMed ID: 20939439
[TBL] [Abstract][Full Text] [Related]
5. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
Pamukcu B; Lip GY
Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
[TBL] [Abstract][Full Text] [Related]
6. Severe toxic hepatitis associated with dronedarone.
Jahn S; Zollner G; Lackner C; Stauber RE
Curr Drug Saf; 2013 Jul; 8(3):201-2. PubMed ID: 23789833
[TBL] [Abstract][Full Text] [Related]
7. Dronedarone: an emerging therapy for atrial fibrillation.
Rosei EA; Salvetti M
Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of dronedarone for patients with atrial fibrillation.
Teme T; Goldberger JJ
Cardiol J; 2013; 20(5):486-90. PubMed ID: 24469871
[TBL] [Abstract][Full Text] [Related]
9. Dronedarone: an overview.
Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
[TBL] [Abstract][Full Text] [Related]
10. A new agent for atrial fibrillation: electrophysiological properties of dronedarone.
Singh BN; Cingolani E
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):6S-14S. PubMed ID: 21098415
[TBL] [Abstract][Full Text] [Related]
11. Dronedarone.
Patel C; Yan GX; Kowey PR
Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
[TBL] [Abstract][Full Text] [Related]
12. Torsade de pointes tachycardia in a patient on dronedarone therapy.
Huemer M; Sarganas G; Bronder E; Klimpel A; Garbe E; Haverkamp W
Pharmacotherapy; 2015 May; 35(5):e61-5. PubMed ID: 25823967
[TBL] [Abstract][Full Text] [Related]
13. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
Garcia D; Cheng-Lai A
Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
[TBL] [Abstract][Full Text] [Related]
14. Drug safety evaluation of dronedarone in atrial fibrillation.
De Ferrari GM; Dusi V
Expert Opin Drug Saf; 2012 Nov; 11(6):1023-45. PubMed ID: 22971242
[TBL] [Abstract][Full Text] [Related]
15. Interaction between digoxin and dronedarone in the PALLAS trial.
Hohnloser SH; Halperin JL; Camm AJ; Gao P; Radzik D; Connolly SJ;
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1019-25. PubMed ID: 25378467
[TBL] [Abstract][Full Text] [Related]
16. Ventricular ectopy and QTc-interval prolongation associated with dronedarone therapy.
Gonzalez JE; Sauer WH; Krantz MJ
Pharmacotherapy; 2013 Oct; 33(10):e179-81. PubMed ID: 23836583
[TBL] [Abstract][Full Text] [Related]
17. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
[TBL] [Abstract][Full Text] [Related]
18. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
Wegener FT; Ehrlich JR; Hohnloser SH
J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
[TBL] [Abstract][Full Text] [Related]
19. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
Dale KM; White CM
Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic profile of dronedarone , a new antiarrhythmic agent for the treatment of atrial fibrillation.
Rosa GM; Bianco D; Parodi A; Valbusa A; Zawaideh C; Bizzarri N; Ferrero S; Brunelli C
Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1751-64. PubMed ID: 25349898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
